Survival outcomes in patients with oropharyngeal cancer treated with carboplatin/paclitaxel and concurrent radiotherapy
Background A commonly employed treatment for advanced staged oropharyngeal squamous cell carcinoma (OPSCC) is concurrent radiation and chemotherapy with cisplatin as the gold standard. Carboplatin is reported to have the same radiopotentiation properties and a superior side effect profile; however,...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAGE Publishing
2016-01-01
|
| Serie: | Journal of Otolaryngology - Head and Neck Surgery |
| Accesso online: | https://doi.org/10.1186/s40463-016-0163-1 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|